Management of Hyperglycemia with Multiple Electrolyte Abnormalities and Neutrophilia
This patient requires immediate initiation of basal insulin therapy along with aggressive fluid resuscitation, correction of electrolyte abnormalities, and urgent evaluation for underlying infection given the marked neutrophilia and constellation of metabolic derangements. 1, 2
Immediate Priority: Rule Out Diabetic Foot Infection or Other Serious Infection
- The marked neutrophilia (85.7% with absolute neutrophil count of 8.80 × 10⁹/L) combined with hyperglycemia strongly suggests an underlying bacterial infection that must be identified and treated urgently 1, 3
- Perform a thorough examination for diabetic foot ulcers, skin infections, or other sources of infection, as diabetic foot infections commonly present with elevated white blood cell counts (often >20 × 10⁹/L) and fever 1
- Obtain blood cultures, inflammatory markers (CRP), and imaging as indicated before starting empiric antibiotics if infection is suspected 1
- The combination of hyperglycemia and infection creates a vicious cycle requiring simultaneous management of both conditions 1
Glycemic Management Algorithm
Step 1: Initiate Insulin Therapy Immediately
- Start basal insulin at 0.1-0.2 units/kg/day given the glucose of 129 mg/dL represents treated or partially controlled hyperglycemia, but the clinical picture suggests recent severe hyperglycemia 2
- The normal eGFR (97.10 mL/min/1.73 m²) allows for standard insulin dosing without renal adjustment 1, 4
- Monitor blood glucose every 2-4 hours initially and titrate insulin to achieve fasting glucose <130 mg/dL 2
- Do not rely solely on the current glucose of 129 mg/dL—this may reflect acute illness, infection-related insulin resistance, or recent treatment 1
Step 2: Add Metformin Once Stable
- Initiate metformin 500 mg once daily with dinner after the acute illness resolves and the patient is eating normally 5
- The eGFR of 97 mL/min/1.73 m² allows full-dose metformin without restriction 4, 5
- Temporarily hold metformin during acute illness, especially if infection with potential sepsis or hemodynamic instability is present 5
- Titrate to 1000 mg twice daily over several weeks as tolerated 5
Step 3: Target HbA1c <7%
- Recheck HbA1c in 3 months to assess glycemic control 5, 2
- Note that HbA1c may underestimate glycemic control in this patient due to anemia (hemoglobin 10.8 g/dL), which can affect red cell lifespan and HbA1c accuracy 4
- Consider more frequent self-monitoring of blood glucose or continuous glucose monitoring for accurate assessment 4
Electrolyte Correction Protocol
Hyponatremia (Sodium 131 mEq/L)
- This is likely hyperglycemic hyponatremia—calculate corrected sodium: add 1.6 mEq/L for every 100 mg/dL glucose above 100 mg/dL 6
- Corrected sodium ≈ 131 + (1.6 × 0.29) = 131.5 mEq/L (still mildly low)
- Avoid rapid correction—increase sodium by no more than 8-10 mEq/L in 24 hours to prevent osmotic demyelination syndrome 6
- Use isotonic saline (0.9% NaCl) for initial fluid resuscitation if infection is present 1, 6
- Monitor sodium every 4-6 hours during active correction 6
Hypocalcemia (Calcium 7.9 mg/dL)
- Check ionized calcium and albumin to determine if this is true hypocalcemia or pseudohypocalcemia from hypoalbuminemia 1, 7
- Corrected calcium = measured calcium + 0.8 × (4.0 - albumin)
- If symptomatic (Trousseau sign, tetany, seizures), give IV 10% calcium gluconate 10-20 mL over 10 minutes 8, 7
- Check magnesium level urgently—hypocalcemia often cannot be corrected until hypomagnesemia is addressed 7
- If magnesium is low, give magnesium sulfate 2-4 g IV over 15-30 minutes before attempting calcium correction 7
- Monitor for cardiac arrhythmias with continuous telemetry if calcium <7.0 mg/dL 1
Chloride and Anion Gap
- Low chloride (90 mEq/L) with normal anion gap (10) suggests appropriate compensation or concurrent metabolic alkalosis 7
- Monitor for metabolic alkalosis, which can occur with hypokalemia (though potassium is currently normal at 3.9 mEq/L) 7
Anemia Management
- The anemia (hemoglobin 10.8 g/dL, hematocrit 32.4%) requires evaluation for iron deficiency, chronic disease, or diabetic kidney disease-related anemia 1
- Check iron studies (ferritin, transferrin saturation, TIBC) to assess for iron deficiency 1
- The elevated RDW (15.1%) suggests possible iron deficiency or mixed anemia 1
- With eGFR >60 mL/min/1.73 m², this anemia is not yet attributable to CKD and requires alternative explanation 1
- Consider occult blood loss, nutritional deficiencies (B12, folate), or anemia of chronic disease from infection 1
Monitoring and Follow-Up
Acute Phase (First 24-48 Hours)
- Blood glucose every 2-4 hours until stable 2
- Sodium every 4-6 hours during correction 6
- Calcium and magnesium every 6-12 hours if abnormal 7
- Complete blood count daily to monitor infection response 1
- Renal function (BUN, creatinine) daily 1
Subacute Phase (Days 3-7)
- Blood glucose 4 times daily (fasting and pre-meals) 2
- Electrolytes every 1-2 days until normalized 1
- Monitor for hypoglycemia risk factors: decreased oral intake, resolution of infection, improving renal function 1
Chronic Management (After Discharge)
- HbA1c every 3 months until target achieved, then every 6 months 5, 2
- Annual screening for diabetic complications: retinopathy, nephropathy (urine albumin-to-creatinine ratio), neuropathy 1
- Monitor eGFR and electrolytes every 3 months given the current metabolic derangements 1
Critical Pitfalls to Avoid
- Do not correct hyponatremia too rapidly—risk of osmotic demyelination syndrome is real and devastating 6
- Do not attempt to correct hypocalcemia without first checking and correcting magnesium—it will be futile and waste time 7
- Do not assume the current glucose of 129 mg/dL reflects adequate control—the clinical picture suggests recent severe hyperglycemia requiring insulin 2
- Do not overlook infection as the primary driver of this presentation—neutrophilia of this magnitude demands urgent infection workup 1, 3
- Do not start metformin during acute illness with potential sepsis—wait until hemodynamically stable 5
- Do not rely on HbA1c alone in the setting of anemia—it may be falsely low 4
- Do not use SGLT2 inhibitors for glycemic control at this stage—while eGFR is normal, they are not appropriate for acute hyperglycemia management and carry infection risks 4